DigiMedical Solutions Inc DGMS
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
DigiMedical Solutions Inc is a United States based company engaged in addressing prescription processing and workflow problems and others by offering an integrated digital medical solution connecting the physician, patient and the pharmacist on a HIPAA compliant private network. Its product comprises; digiRX(c) which is a digital prescribing technology that provides the seamless connection between doctors, patients and pharmacist; digiReAuth(c) which is prescription re-authorization/refill product where Doctors, patients and pharmacist prevents time-consuming process of multiple phone calls to get a single prescription re-authorized/refilled; and digiReAuth(c) which handles patients and pharmacy's request with a live person and submits these request to the doctor in real time.